Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report

High-dose romiplostim accelerates hematologic recovery in patients with aplastic anemia refractory to eltrombopag

(2020) Kohei Hosokawa et al.   LEUKEMIA

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

(2019) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Early and late hematologic toxicity following CD19 CAR-T cells

(2019) Shalev Fried et al.   BONE MARROW TRANSPLANTATION

Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment

(2019) Yang Liu et al.   AMERICAN JOURNAL OF HEMATOLOGY

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells

(2019) Ana Cordeiro et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial

(2019) Régis Peffault de Latour et al.   BLOOD

The Pathophysiology of Acquired Aplastic Anemia

(2018) Michelle L. Schoettler et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

(2017) Sattva S. Neelapu et al.   Nature Reviews Clinical Oncology

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy

(2017) Eileen Shiuan et al.   Journal for ImmunoTherapy of Cancer

Toxicities of chimeric antigen receptor T cells: recognition and management

(2016) Jennifer N. Brudno et al.   BLOOD

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug

(2013) R. Desmond et al.   BLOOD

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

(2010) A Fontanet et al.   BONE MARROW TRANSPLANTATION